Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L7OY
|
||||
| Former ID |
DIB000020
|
||||
| Drug Name |
D-7193
|
||||
| Synonyms |
D-7042
|
||||
| Indication | Immuno-modulator [ICD9: 135, 691.8, 692.9, 710-719, 714; ICD10:D86, L20, L20-L30, M00-M25, M05-M06] | Discontinued in Phase 2 | [1] | ||
| Company |
Astra AB
|
||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007192) | ||||
| REF 2 | US patent application no. 6,673,908, Tumor necrosis factor receptor 2. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.